Skip to content

CORONIS

Active Private limited companyfounded 2007active for 18 yearsSegershoevestraat 12, 2570 DuffelKBO/BCE: BE 0894.052.166 #6 oldest company in Duffel, Health and social work sector
CORONIS
Follow ReportCompare

Overview

Lifetime

18 annual accounts with figures on one time axis
peak €152,389 (2022)
€72,183▲ 100%
peak €102,518 (2022)
€47,246▲ 187%
peak €307,116 (2023)
€281,674▼ 3.1%
€20,580▼ 64.9%
Board1 name since 2007
1 directorDE VOECHT Jo
Documentsfilings and deeds
01-07-202630 days before the deadline
2025micro format
Gross margin from €36,013 to €72,183Result from €16,447 to €47,246Dividend €43,728Debts from €58,631 to €20,580

Key points

from the 2025 annual accounts

Equity

€281,674 ▼ 3.1%
290,5572024+47,246Profit-43,728Dividend-12,400Other281,6742025

CORONIS paid out €43,728 in dividends. That is 93% of the 2025 profit.

Liquidity

13.79 was 5.52 in 2024

Short-term debts fell from €58,631 to €20,580.

Position in the sector

93.2%

Higher solvency than 88% of companies in human health. Sector median 63.0% · 20,774 companies.

Checked score

95
Excellent
Financially stronger than 63% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026

Financial strength
Strong

100=equity 93.2% of total assets
100+4short-term debt 6.8% · cash 90.5%
88+13return on assets 15.6%

Score breakdown

lowers risk
Liquidity: current ratio 13.79, cash €273,621
Sector: Human health activities (NACE 86)
Equity €281,674 (93.2% of total assets)
Size: total assets €302,255
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 42% on profitability and 32% on growth.

The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 34,693 companies had the same profile as CORONIS has now. Each dot stands for 87 companies, two years later.

95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

That fits the bankruptcy probability of CORONIS itself: < 0.1% within 12 months.

Test of the method

The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,693 companies, not a prediction for CORONIS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €25,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 13.79 (5.52 in 2024), above the usual 1.5. Short-term debt is 6.8% and cash 90.5% of total assets. 6.8% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

5 signals, none raises the risk
Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 13.79, cash €273,621
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €281,674 (93.2% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €302,255
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
30 days early
2024
28 days early
2023
12 days early
2022
20 days early
2021
33 days early
2020
31 days late
2019
38 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 19 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

DV
DE VOECHT Jo
Director, since 16-11-2007
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0894052166
Resignation: DE VOECHT Jo (director) Reappointment: DE VOECHT Jo (director) · General meeting of 16-11-2023 · Gazette deed
Capital decrease of €56,400 to €18,600 Capital from €75,000 to €18,600 · General meeting of 05-06-2018 · Gazette deed
Incorporation published on 18-12-2007 · Gazette deed
All 32 events

Comparable companies

same main activity, similar in size and age
Company
CORONIS Duffel €302,255 €72,183 93.2% -
CHIROPRAXIE NOLMANS Lubbeek €295,525 €74,497 26.4% -
TIMMERMANS PHILIPPE Brussels €238,838 €68,500 93.1% -
OSTEO Kalmthout €331,959 €54,007 58.7% -
Pure Health Geel €419,821 €58,026 33.2% -
Roeymans-Geeraerts Mol €464,722 €78,308 62.0% -
B-FYSIO Beveren-Kruibeke-Zwijndrecht €305,970 €98,844 33.7% -

These companies have the same main activity as CORONIS: nutrition and dietetics services (NACE 86995). They are comparable in size and age: total assets between €239,000 and €465,000, founded between 2006 and 2012.

Official details

Source: KBO
Status
Active since 16-11-2007Normal situation
Activity
Nutrition and dietetics servicesNACE 86995and 1 other
Establishment unit
2.167.846.9612570 Duffel, since 16-11-2007
Financial year end
31 December
Peppol
Reachable since 29-10-2025
Company details

Annual accounts 2025

€72,183▲ 100%
≈ €200,000estimated
€47,246▲ 187%
€281,674▼ 3.1%
€302,255▼ 13.4%
Filing
Filed on 01-07-2026, 30 days before the end of the filing period
Financials

Insights on CORONIS

CORONIS files the micro format. That format states no turnover. The gross margin rose from €22,379 in 2008 to €72,183 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 01-07-2026, 30 days before the deadline
€72,183
▲ 100%
€63,983
▲ 136%
€47,246
▲ 187%
€263,221
▼ 0.8%
93.2%
▲ 10.0 percentage points
13.79
▲ 8.27

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €200,000. Estimated: probably between €130,000 and €290,000.

In the rankings #6 oldest company in Duffel, Health and social work sector

Balance sheet

balance sheet total €302,255 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

93.2%

Higher than 89% of 20,774 companies in 2025.

13.79

Higher than 88% of 20,348 companies in 2025.

15.6%

Higher than 39% of 20,630 companies in 2025.

CORONIS Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: top quarter

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023202220212020201920182017201620152014201320122011201020092008
Balance sheet: assets
20/58 302,255349,188371,649275,435177,279161,047122,684117,261149,629120,176115,323102,752101,12286,46886,29865,00253,53231,626
21/28 18,45325,25924,35016,1346,8236,9492,8745,4337,7874,5245,1095,8466,4095,6068,3105,1024,726862
22/27 18,45325,25924,35015,1346,8236,9492,8745,4337,7874,5245,1095,8466,4095,6068,3105,1024,726862
22 857960----6401,2815667559431,1321,3211,5091,698---
23 5,0466,2497,9132,421664718761,3771,548288384----174347-
24 9,82314,95812,98212,7136,7576,4781,3572,7755,6733,4813,7824,7145,0884,0966,6124,9294,379862
26 2,7283,091----------------
27 --3,455---------------
28 ---1,000--------------
29/58 283,801323,929347,299259,301170,457154,098119,810111,828141,841115,652110,21496,90694,71380,86277,98859,90048,80730,764
40/41 6,16633,64437,41262,59740,23521,50922,56517,41238,66115,3648,85737,26824,23816,3009,06212,0938,36613,941
40 032,04830,47544,26938,77918,51315,97215,26234,72011,4228,85733,95721,0499,8529,0628,0937,2552,724
41 6,1661,5966,93718,3281,4562,9966,5932,1493,9423,942-3,3113,1896,448-4,0001,11111,217
54/58 273,621287,176306,604193,766127,311131,37896,68094,317103,180100,287101,35759,63870,47564,56268,69547,80640,44016,823
490/1 4,0143,1093,2832,9392,9111,21156599------232---
Balance sheet: equity and liabilities
10/49 302,255349,188371,649275,435177,279161,047122,684117,261149,629120,176115,323102,752101,12286,46886,29865,00253,53231,626
10/15 281,674290,557307,116251,460160,279150,979114,177104,144132,356115,168103,83191,71029,18284,18678,68757,76545,73726,376
10/11 012,40012,40012,40012,40012,40012,40012,40068,80068,80068,80068,80012,40012,40012,40012,40012,40012,400
100 ------18,60018,60075,00075,00075,00075,00018,60018,60018,60018,60018,60018,600
101 ------6,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,200
13 281,674278,157291,758236,103144,922135,62298,81988,78760,59843,41132,0747,9881,8601,8601,8601,8601,8601,860
130/1 --1,8601,8601,860-------------
130 ------7,5007,5007,5007,5007,5002,1701,8601,8601,8601,8601,8601,860
1311 --1,8601,8601,860-------------
133 281,674278,157289,898234,243143,062135,62291,31981,28753,09835,91124,5745,818------
14 002,9572,9572,9572,9572,9572,9572,9572,9572,95714,92214,92269,92664,42743,50531,47712,116
17/49 20,58058,63164,53323,97517,00110,0688,50713,11617,2735,00711,49211,04271,9402,2817,6117,2377,7965,250
17 -036,875---------------
176 -036,875---------------
42/48 20,58058,63127,65923,97517,00110,0688,50713,11617,2735,00711,49211,04271,9402,2817,4367,2377,7965,250
44 2,21231,0522,7562,9332,5212,7052654444,1832413,5084,6374,0108673438842,2684,535
440/4 2,21231,0522,7562,9332,5212,7052654444,1832413,5084,6374,0108673438842,2684,535
45 9,09416,33614,69111,8706,3666792,6248,41011,3602,3996,2663,8769,5061021,7943,5883,528710
450/3 9,09416,33614,69111,8706,3666792,6248,41011,3602,3996,2663,8769,5061021,7943,5883,528710
47/48 9,27411,24310,2119,1728,1146,6835,6184,2621,7302,3681,7192,52958,4251,3125,2992,7652,0005
492/3 --------------175---
Income statement
76A ---0--13---120---0-
9900 72,18336,013110,295152,38952,37365,08421,36846,75235,46924,04925,60114,59214,90113,62733,67620,46331,73022,379
630 6,8057,5776,4104,9803,8824,0354,1454,0394,7812,7252,9532,8093,6802,7052,8782,0831,591431
640/8 1,3941,3501,2721,1611,1801,3029911,0269241,5929481,0148841,796879733386840
66A ----12-----1---2--
9901 63,98327,085102,612146,24847,31059,74416,23241,68629,76419,73221,69910,76910,3379,12729,91917,64629,75321,109
75/76B 0210-00---1301391,51833314352436
75 0210-00---1301391,51833314352436
65/66B 111637878691206431,1461,6431,6384438801,1221,2315871,0611,4071,515
65 111637878691206431,1461,6431,6254438801,1221,2315871,0611,4071,515
66B ---------13--------
9903 63,97226,943102,534146,17047,24059,62415,58840,54028,12118,09521,28710,03010,7537,92929,64616,61828,37019,630
67/77 16,72610,49629,69143,65213,54417,0045,55612,35110,9346,7589,1653,9023,0912,4308,7234,5907,0095,654
9904 47,24616,44772,843102,51833,69642,62010,03228,18917,18711,33712,1226,1287,6625,49920,92312,02821,36113,976
9905 47,24616,44772,843102,51833,69642,62010,03228,18917,18711,33712,1226,1287,6625,49920,92312,02821,36113,976
Appropriation of the result
9906 47,24616,44775,800105,47536,65345,57712,98931,14620,14414,29427,04321,05077,58869,92664,42743,50533,47713,976
14P -02,9572,9572,957-------------
791/2 43,72833,00617,18711,33724,3965,818------------
691/2 47,24616,44772,843102,51833,69642,62010,03228,18917,18711,33724,0866,128-----1,860
6920 ----------5,330310-----1,860
6921 47,24616,44772,843102,51833,69642,62010,03228,18917,18711,33718,7565,818------
694/7 43,72833,00617,18711,33724,3965,818------62,667---2,000-
694 43,72833,00617,18711,33724,3965,818------62,667-----
695 ----------------2,000-
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 01-07-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 01-07-2026 2026-00231741 PDF
31-12-2024 micro format 03-07-2025 2025-00228517 PDF
31-12-2023 micro format 19-07-2024 2024-00265519 PDF
31-12-2022 micro format 11-07-2023 2023-00224400 PDF
31-12-2021 micro format 28-06-2022 2022-20100514 PDF
31-12-2020 micro format 31-08-2021 2021-60500153 PDF
31-12-2019 micro format 23-06-2020 2020-19500056 PDF
31-12-2018 micro format 14-06-2019 2019-18400387 PDF
31-12-2017 micro format 06-07-2018 2018-29600378 PDF
31-12-2016 micro format 16-06-2017 2017-17900091 PDF
31-12-2015 abbreviated format 16-07-2016 2016-32800538 PDF
31-12-2014 abbreviated format 04-06-2015 2015-14900443 PDF
31-12-2013 abbreviated format 06-06-2014 2014-16100004 PDF
31-12-2012 abbreviated format 12-07-2013 2013-30000258 PDF
31-12-2011 abbreviated format 27-06-2012 2012-22200082 PDF
31-12-2010 abbreviated format 10-06-2011 2011-15700483 PDF
31-12-2009 abbreviated format 11-06-2010 2010-16900552 PDF
31-12-2008 abbreviated format 25-06-2009 2009-29500018 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023202220212020201920182017201620152014201320122011201020092008
70,78934,663109,023151,22851,19263,77920,37745,72534,54622,45724,65213,57914,01711,83132,79719,73031,34421,540
54,05124,02579,253107,49937,57846,65514,17732,22821,96914,06215,0758,93711,3428,20423,80114,11122,95214,407
08,48615,62614,2923,7568,1101,5861,6858,0452,1392,2162,2474,48306,0862,4605,4551,293
-13,554-19,429112,83966,455-4,06834,6982,362-8,8632,893-1,07041,719-10,8375,913-4,13220,8887,36623,617-
263,221265,298319,641235,326153,456144,030111,30398,711124,568110,64498,72285,86422,77378,58170,55252,66241,01125,514
93.2%83.2%82.6%91.3%90.4%93.7%93.1%88.8%88.5%95.8%90.0%89.3%28.9%97.4%91.2%88.9%85.4%83.4%
13.795.5212.5610.8210.0315.3114.088.538.2123.109.598.781.3235.4410.498.286.265.86
0.070.200.210.100.110.070.070.130.130.040.110.122.470.030.100.130.170.20
16.8%5.7%23.7%40.8%21.0%28.2%8.8%27.1%13.0%9.8%11.7%6.7%26.3%6.5%26.6%20.8%46.7%53.0%
15.6%4.7%19.6%37.2%19.0%26.5%8.2%24.0%11.5%9.4%10.5%6.0%7.6%6.4%24.2%18.5%39.9%44.2%
over 100over 100over 100over 100over 100-------------

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets-€8,486€15,626€13,292€3,756
Financial fixed assets---€1,000-
€6,805€7,577€6,410€4,980€3,882

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on CORONIS

The operating result for 2025 is 136% higher than in 2024. It is a recovery after the fall in 2024.

Debt's share of the balance-sheet total falls from 16.8% to 6.8%. Equity and debt are lower.

Board & ownership

Board

1 director, last change in 2023
DE VOECHT Jo
Director (not named in the articles)
since 16-11-2007 term without a fixed end
earlier director, until 21-11-2023
listed in the 2025 annual accounts, filed on 01-07-2026

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
DE VOECHT Jo
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
  • DE VOECHT Jo
    • Director (not named in the articles), from 16-11-2007 to date
    • Director, until 21-11-2023

See the board, name and registered office on a given date →

Control

See the annual accounts at the National Bank and the publications in the Belgian Official Gazette.

Capital

Contribution
€12,400
Shares
186
Contribution per share
€66.67
Equity per share
€1,514 in 2025
Source
2024 annual accounts

Articles of association

deed of 21-11-2023 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited

Capital transactions

Capital over time
  1. 21-11-2023 Capital stated in the deed · 186 shares
  2. 21-06-2018 Capital reduction of €56,400 · to €18,600 · repaid to the shareholders

Network & group

No group

CORONIS has no parent and no holdings in its annual accounts. DE VOECHT Jo is the only director. CORONIS shares no director with another company.

Timeline

Timeline

32 events since 2007

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBmicro format · 30 days before the deadline
2025
Liquidity more than doubled current ratio 13.79 The current ratio rises from 5.52 to 13.79. Short-term debt falls from €58,631 to €20,580.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0894052166
Annual accounts 2024 filed PDFmicro format · 28 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 12 days before the deadline
2023
Resignation: DE VOECHT Jo (director)Reappointment: DE VOECHT Jo (director) · General meeting of 16-11-20235 points ▸
  • General meeting, 16-11-2023
  • 186 shares
  • Director resignation, DE VOECHT Jo
  • Director reappointment, DE VOECHT Jo (director (not named in the articles))
  • Registered office clause, Segershoevestraat 12, 2570 Duffel
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2022 filed PDFmicro format · 20 days before the deadline
2022
Highest result from 2008 to 2025 net €102,518 ▲204% The operating result of €146,248 and the net result of €102,518 are both a record.
Equity above €200,000 equity €251,460 ▲56.9% Equity rises from €160,279 to €251,460.
Annual accounts 2021 filed PDFmicro format · 33 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 31 days late
2020
Equity above €150,000 equity €150,979 ▲32.2% Equity rises from €114,177 to €150,979.
Annual accounts 2019 filed PDFmicro format · 38 days before the deadline
2019
Annual accounts 2018 filed PDFmicro format · 47 days before the deadline
2018
Annual accounts 2017 filed PDFmicro format · 25 days before the deadline
Capital decrease of €56,400 to €18,600Capital from €75,000 to €18,600 · General meeting of 05-06-20183 points ▸
  • General meeting, 05-06-2018
  • Capital decrease, €56,400
  • Capital, €18,600, 186 shares
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

2017
Annual accounts 2016 filed PDFmicro format · 45 days before the deadline
2016
Liquidity more than doubled current ratio 23.10 The current ratio rises from 9.59 to 23.10. Short-term debt falls from €11,492 to €5,007.
Annual accounts 2015 filed PDFabbreviated format · 15 days before the deadline
2015
Equity above €100,000 equity €103,831 ▲13.2% Equity rises from €91,710 to €103,831.
Annual accounts 2014 filed PDFabbreviated format · 57 days before the deadline
2014
Liquidity more than 6 times current ratio 8.78 The current ratio rises from 1.32 to 8.78. Short-term debt falls from €71,940 to €11,042.
Annual accounts 2013 filed PDFabbreviated format · 55 days before the deadline
2013
Annual accounts 2012 filed PDFabbreviated format · 19 days before the deadline
2012
Weakest financial year net €5,499 ▼73.7% The net result drops to €5,499, the lowest from 2008 to 2025. It recovers the following year.
Liquidity more than triples current ratio 35.44 The current ratio rises from 10.49 to 35.44. Short-term debt falls from €7,436 to €2,281.
Annual accounts 2011 filed PDFabbreviated format · 34 days before the deadline
2011
Annual accounts 2010 filed PDFabbreviated format · 51 days before the deadline
2010
Annual accounts 2009 filed PDFabbreviated format · 50 days before the deadline
2009
Annual accounts 2008 filed PDFabbreviated format · 36 days before the deadline
2007
Incorporation PDFpublished on 18-12-2007
First establishment Segershoevestraat 12, Duffel

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

CORONIS was incorporated on 16 November 2007.1 Total assets rose from €117,261 in 2018 to €302,255 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Company details

Identity

Enterprise number
0894.052.166
VAT number
BE 0894.052.166
Peppol ID
0208:0894052166
Other Peppol ID
9925:BE0894052166
Legal form
Private limited company
Status
Active, normal situation
Founded
16-11-2007
Financial year
ends on 31 December
Peppol
Reachable since 29-10-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
CORONIS in Dutch
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 21-11-2023 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest”
deed of 21-11-2023 (in Dutch)

Activities

NACEBEL 2025
86995 Nutrition and dietetics services main activity
86910 Medical imaging and medical laboratories
Codes under NACEBEL 2008
86909 Human health activities main activity
86901 Human health activities
PurposeThe purpose describes the activities the company may carry out under its articles.
“Alle activiteiten die in verband staan met klinisch onderzoek naar geneesmiddelen en andere medische producten,zowel in opdracht van…”
8 activities
  1. Alle activiteiten die in verband staan met klinisch onderzoek naar geneesmiddelen en andere medische producten,zowel in opdracht van ziekenhuizen,huisartsenpraktijken en andere plaatsen van medische beroepsuitoefening,als in opdracht van de industrie.Deze activiteiten betreffen zowel het verrichten van complete klinische studies,dan wel het uitoefenen van deeltaken die hiermee verband houden zoals onder meer:plannings-activiteiten,training en onderwijs,haalbaarheidsstudies,werving van onderzoekers en experts,monitoring van klinische studies,inhouse review of dubbele controle,project management en coordinatie,kwaliteitscontrole,projectassistentie,data entry of het invoeren van gegevens,statistische bewerking,assistentie bij registratie,rapportage;
  2. Het verstrekken van advies en het verlenen van begeleiding aan bedrijven met name in de medische en pharmaceutische sector;
  3. Het organiseren van colloquia,seminaries en congressen,het houden van voordrachten en lezingen en het uitgeven van publicaties;
  4. Het verlenen van management en ondersteuning in het algemeen aan andere ondernemingen;
  5. Het optreden als bestuurder en vereffenaar van andere vennootschappen;
  6. Het beheren,uitbaten,valoriseren,huren en verhuren,verwerven of vervreemden van alle roerende en onroerende goederen,het verkavelen,ordenen,het doen bouwen of verbouwen van onroerende goederen,evenals alle roerende en onroerende handelingen in de meest ruime zin.
  7. Daartoe kan de vennootschap samenwerken met,deelnemen in,of op gelijk welke wijze,rechtstreeks ofonrechtstreeks,belangen nemen in andere ondernemingen.
  8. De vennootschap kan zowel tot waarborg van eigen verbintenissen als tot waarborg van verbintenissen van derden borgstellen,onder meer door haar goederen in hypotheek of in pand te geven,inclusief de eigen handelszaak.
deed of 21-11-2023 (in Dutch)

Registered office and establishments

1 establishment
Establishment Since Unit number
Segershoevestraat 12 registered office 2570 Duffel 16-11-2007 2.167.846.961

Buildings and parcels at the address

Ground area
673 m²
Buildings
126 m²
Volume, LiDAR
728 m³
Tallest building
10.5 m
Buildings to scale, each on its own parcel
126 m², 10.5 m 126 m², 10.5 m

Location

registered office establishment The establishment unit on the map

Parcels

Cadastral parcelArea Buildings Height / floors
12009A0502/00D005673 m² 1 · 126 m² 10.5 m · 2

We would like to set cookies. That happens only with your consent. What we measure